Atea Pharmaceuticals will hold a live conference call on November 9, 2026, to announce its financial results for the third quarter ending September 30, 2026, and provide a business update. The company is a late-stage biopharmaceutical firm focused on developing oral antiviral therapies for serious viral infections, including hepatitis C and hepatitis E. Investors can access the call via registration, and a webcast archive will be available on Atea's website. This update is important as Atea advances its antiviral drug pipeline and Phase 3 clinical programs.
Atea Pharmaceuticals will announce its Q3 2026 financial results on November 9, 2026. For readers following the health sector, here is Pluang's market snapshot as of Nov 03, 2026 04:11 WIB: out of 150 US health stocks, 48 rose and 100 fell. Notable movers include HIMS at USD 25.22 with a -8.89% change and 100% buy order activity, TVTX at USD 46.00 down 8.71%, and NTRA at USD 379.01 down 8.49%.
Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...
Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
The FDA placed Bright Minds Biosciences' planned Phase 2 epilepsy trial for BMB-101 on partial clinical hold due to toxicity findings in mice and insufficient pharmacokinetic and juvenile-toxicity data. This action caused a sharp decline in the compa...
NVIDIA has published detailed implementation recipes for its Cosmos world models, enabling developers to create simulations for vehicles, robots, and surgical procedures. These recipes guide model adaptation, testing, and GPU deployment, supporting v...
